Work for Allogene Therapeutics, Inc.?

Claim Your Profile

Allogene Therapeutics, Inc. Logo Image

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. Banner Image

About Allogene Therapeutics, Inc.

201-500 Employees
Based in South San Francisco, California

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.

Ticker:
ALLO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol